Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Drugs

Analgin-Darnitsa

Analgesics and antipyretics

Nonsteroidal anti-inflammatory drug, a pyrazolone derivative. Nonselectively inhibits cyclooxygenase, decreases prostaglandin production from arachidonic acid.

Mild and moderate pain of various origin and location (headache, toothache, burns, postoperative pain, dysmenorrhea, arthralgia, neuralgia, radiculitis, myositis); hyperthermia syndrome, fever (in influenza, acute respiratory and other infections); renal and biliary colic (in combination with antispasmodic agents).

Analgin-Darnitsa is used as intramuscular injection and intravenous push. The method of administration and dose depend on the disease severity and should be selected individually. The analgesic effect after an intravenous injection is stronger than after an intramuscular one.

The injected solution must be at body temperature. To avoid a sudden drop in blood pressure, the intravenous administration should be done slowly (at no more than 1 mL/min), the patient should be lying down with the necessary control of blood pressure, heart rate, and respiratory rate. The procedure should be performed in a setting where shock treatment is available. A long needle must be used for intravenous injection.

Adults are administered 0.5–1 mL (250–500 mg) 2–3 times daily. The maximum single dose for both routes of administration is 1 mL (500 mg), daily, 2 mL (1 g).

Children under 1 year old should be administered 0.01 mL/kg of body weight. In children under 1 year old, the drug should only be injected intramuscularly.

Duration of use is up to 3 days.

Children over 1 year old should be administered 0.1 mL for each 1 year of age 1–2 times daily. Duration of use is up to 3 days.

Specialized edition for medical institutions and doctors.